
A Chinese pharmaceutical company, Grand Pharma, hired a lobbying firm led by a Trump Jr. associate to fight a national security challenge from American startup FastWave. CFIUS rejected FastWave's petition to force divestment, allowing Grand Pharma to retain its 40 percent stake. FastWave claims the Chinese investor threatens access to sensitive military technology. Critics question whether political connections influenced the decision.